HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US TELL FRIEND RSS
 
Welcome to FDAweb
Pay Per View
Search our 57,767 - story database FREE
 
Free Items
 Warning Letters
 FDA Notices
 FDA Calendar
 

 FDA Whistleblowers



    








 
 
<< Prev  13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Next >>
 
TXT Attorneys Weigh FDA Reporting of Cybersecurity Upgrades [1748 Words] [ Price : $8.95]
A client alert by DLA Piper attorneys reviews when a cybersecurity-related change to a device is reportable to FDA.
10/31/2016
 
 
TXT FDA Allows Marketing of Becton Dickinson Vaginitis Assay [1169 Words] [ Price : $8.95]
FDA approves a de novo petition to allow marketing of a Becton Dickinson molecular test to detect the most common causes of vaginitis.
10/31/2016
 
 
TXT FDA Clears Onkos Limb Salvage System [1121 Words] [ Price : $8.95]
FDA clears an Onkos Surgical 510(k) for the Eleos Limb Salvage System to treat patients with significant bone loss due to cancer, trauma, or previous surgical procedures.
10/31/2016
 
 
TXT FDA, Catalyst Agree on Trial Protocol for LEMS Therapy [1175 Words] [ Price : $8.95]
FDA and Catalyst Pharmaceuticals reach an agreement under a special protocol assessment for the protocol design, clinical endpoints, and statistical analysis approach in an upcoming Phase 3 study evaluating Firdapse (amifampridine phosphate) for the symptomatic treatment of Lambert-Eaton myasthenic syndrome.
10/31/2016
 
 
TXT Lawmakers Face Tug-of-war Over 21st Century Cures Bills [1423 Words] [ Price : $8.95]
Medical research groups call on the House and Senate leadership to pass the 21st Century Cures Act when they return to work in November, while some liberal groups urge its delay while changes are considered to reign in drug costs.
10/31/2016
 
 
TXT Washington Legal Foundation Examines Off-label Promotion [1515 Words] [ Price : $8.95]
A Washington Legal Foundation legal backgrounder examines the recent convictions of two Acclarent (Johnson & Johnson subsidiary) executives in U.S. v. Facteau (see story) and the questionable boundaries that currently separate speech from criminal conduct.
10/28/2016
 
 
TXT Comments Sought on BLA Reporting Requirements Extension [1107 Words] [ Price : $8.95]
Federal Register Notice: FDA seeks comments on a submission to OMB seeking to extend an information collection related to BLA general licensing provisions.
10/28/2016
 
 
TXT Comments Sought on Device Educational Program Surveys Extension [1120 Words] [ Price : $8.95]
Federal Register Notice: FDA seeks comments on a submission to OMB seeking to extend an information collection related to “Testing Communications on Medical Devices and Radiation-Emitting Products.”
10/28/2016
 
 
TXT FDA OKs St. Jude Stroke Reducing Device [1341 Words] [ Price : $8.95]
FDA approves a St. Jude Medical PMA for the Amplatzer PFO Occluder device to reduce the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot that passed through a small hole in the heart.
10/28/2016
 
 
TXT FDA Guidance on Essure-type Device Labeling and Warnings [1192 Words] [ Price : $8.95]
FDA releases a guidance on “Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization” that addresses the necessary warnings and risk information to inform healthcare providers and patients before such procedures are performed.
10/28/2016
 
 
<< Prev  13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  Next >>
 

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com